Gabapentin Capsule
Product Images NDC 23155-866

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 23155-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cockcroft And Gault Equation (3db34064 46bf 470d Aa9a 66c363c27fa6 01)

A formula illustrating the calculation for creatinine clearance (CLCr), incorporating variables for age, weight, serum creatinine concentration, and adjusted by a factor for female patients.*

FDA Label Image

Image (3db34064 46bf 470d Aa9a 66c363c27fa6 02)

Chemical structure diagram of gabapentin showing the cyclohexane ring attached to an amino methyl group and a carboxymethyl group.*

FDA Label Image

Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (3db34064 46bf 470d Aa9a 66c363c27fa6 03)

A line graph depicting mean pain scores over an 8-week period comparing placebo and gabapentin at 3600 mg/day. The x-axis represents weeks from baseline to week 8 with a 4-week dose titration period followed by a 4-week fixed dose period, while the y-axis shows mean pain scores from 0 to 10. Gabapentin shows a decreasing pain score trend, whereas placebo remains relatively stable.*

FDA Label Image

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (3db34064 46bf 470d Aa9a 66c363c27fa6 04)

Line graph depicting mean pain scores over a 7-week period for placebo and gabapentin at doses of 1800 mg/day and 2400 mg/day. The x-axis shows weeks from baseline, and the y-axis shows mean pain score from 0 to 10. The graph indicates a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥ 50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (3db34064 46bf 470d Aa9a 66c363c27fa6 05)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) dosages in two studies. Study 1 shows 12% for placebo and 29% for GBP 3600, Study 2 shows 14% for placebo, 32% for GBP 1800, and 34% for GBP 2400. Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥ 12 Years Of Age With Partial Seizures (3db34064 46bf 470d Aa9a 66c363c27fa6 06)

A scatter plot chart comparing difference percentages by daily doses of gabapentin in milligrams for three studies labeled 'a', 'b', and 'c'. The x-axis represents the daily dose (600 to 1800 mg), and the y-axis shows the difference in percentage (2% to 22%). Study 'a' is marked with black squares, study 'b' with gray squares, and study 'c' white squares.*

FDA Label Image

Logo (3db34064 46bf 470d Aa9a 66c363c27fa6 07)

FDA Label Image

Logo (3db34064 46bf 470d Aa9a 66c363c27fa6 08)

FDA Label Image

Gabapentin Capsules 300mg (100S)

Label for Gabapentin Capsules, USP 300 mg by Avet Pharma, containing 100 capsules. The label includes dosing information, child-resistant packaging details, manufacturer and distributor information, and barcodes. It states storage instructions and directs pharmacists to dispense the accompanying Medication Guide with each prescription.*

FDA Label Image

Gabapentin Capsules 400mg (100S)

Label for Gabapentin Capsules, USP 400 mg manufactured for Avet Pharmaceuticals Inc. The label indicates 100 capsules in the package for oral use. It includes storage instructions, a note to dispense the Medication Guide, and manufacturer details including Strides Pharma Science Ltd. The label also shows child-resistant packaging information and batch detail space.*

FDA Label Image

Cont-label-100mg-100s (3db34064 46bf 470d Aa9a 66c363c27fa6 11)

Gabapentin Capsules USP 100 mg label for a 100-capsule bottle. The label states dosage form as capsules with a strength of 100 mg each. It includes usage instructions, storage conditions, and child-resistant packaging details. The product is manufactured by Strides Pharma Science Ltd. and marketed by Avet Pharmaceuticals Inc. The label includes NDC 23155-866-01 and advises dispensing the Medication Guide with the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.